Discovery of Novel Enhancers of Isoniazid Toxicity in Mycobacterium tuberculosis

The number of effective first-line antibiotics for the treatment of Mycobacterium tuberculosis infection is strongly limited to a few drugs. Due to emerging resistance against those drugs, second- and third-line antibiotics have been established in therapy with certain problems and also increasing m...

詳細記述

書誌詳細

出版年:	Molecules
主要な著者:	Fabian Lentz, Norbert Reiling, Ana Martins, Joseph Molnár, Andreas Hilgeroth
フォーマット:	論文
言語:	英語
出版事項:	MDPI AG 2018-04-01
主題:	antibacterial enhancing activity synthesis derivatives structure-activity lead structure
オンライン･アクセス:	http://www.mdpi.com/1420-3049/23/4/825